Header Logo

Connection

MOHAMED HEGAZY to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications MOHAMED HEGAZY has written about Antibodies, Monoclonal, Humanized.
MOHAMED HEGAZY
Connection Strength
0.176
Antibodies, Monoclonal, Humanized
  1. Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry. Semin Arthritis Rheum. 2026 Oct; 80:153030.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.